PetIQ, Inc. operates as a pet health and wellness company. It provides veterinarian services and veterinarian-grade pet products, including prescription (Rx) medications, over-the-counter (OTC) flea and tick preventatives, and health and wellness products for dogs and cats. The company offers pet prescription medications, including products for arthritis, thyroid, and diabetes and pain treatments, as well as heartworm preventatives, antibiotics, and other specialty medications; over-the-counter medications and supplies, such as flea and tick control products in various forms comprising spot on treatments, chewables, and collars; and health and wellness products consisting of specialty treats and other pet products, which include dental treats and nutritional supplements. The company provides its products primarily under the VetIQ, PetAction Plus, Advecta, PetLock Plus, and TruProfen brands. It sells its products through approximately 60,000 points of distribution across retail and e-commerce channels. PetIQ, Inc. was founded in 2010 and is headquartered in Eagle, Idaho.
Industry, Sector and Symbol
Industry Drugs, proprietaries, & sundries
Sub-IndustryN/A
SectorMedical
Phone208-939-8900
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$266.69 million
Profitability
Miscellaneous
Employees225
OptionableOptionable
PetIQ (NASDAQ:PETQ) Frequently Asked Questions
What is PetIQ's stock symbol?
PetIQ trades on the NASDAQ under the ticker symbol "PETQ."
How were PetIQ's earnings last quarter?
PetIQ Inc (NASDAQ:PETQ) released its quarterly earnings data on Tuesday, November, 13th. The company reported $0.47 EPS for the quarter, topping analysts' consensus estimates of $0.25 by $0.22. The firm earned $131.40 million during the quarter, compared to the consensus estimate of $125.22 million. PetIQ had a negative net margin of 0.12% and a positive return on equity of 11.68%. The firm's revenue was up 116.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.30 earnings per share. View PetIQ's Earnings History.
When is PetIQ's next earnings date?
What guidance has PetIQ issued on next quarter's earnings?
PetIQ issued an update on its FY 2018 earnings guidance on Tuesday, November, 13th. The company provided EPS guidance of for the period. The company issued revenue guidance of $515-515 million, compared to the consensus revenue estimate of $502.34 million.
What price target have analysts set for PETQ?
5 analysts have issued 1-year price objectives for PetIQ's stock. Their predictions range from $39.00 to $50.00. On average, they expect PetIQ's share price to reach $44.00 in the next twelve months. This suggests a possible upside of 58.6% from the stock's current price. View Analyst Price Targets for PetIQ.
What is the consensus analysts' recommendation for PetIQ?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PetIQ in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for PetIQ.
What are Wall Street analysts saying about PetIQ stock?
Here are some recent quotes from research analysts about PetIQ stock:
- 1. Jefferies Financial Group Inc analysts commented, "PETQ remains our top small-cap growth idea post our mgmt meetings / co.’s bullish presentation at the ICR conf. in Orlando, FL. Mgmt underscored secular tailwinds in the attractive pet health industry remain very much in place, the co." (1/15/2019)
- 2. According to Zacks Investment Research, "PetIQ, Inc. is a pet medication and wellness company. Its product consists of Rx Medications, OTC Medications and Supplies, Health and Wellness Products. The Company serves retail stores across the mass, club, grocery, pharmacy and e-commerce channels. PetIQ, Inc. is based in Eagle, United States. " (6/6/2018)
Has PetIQ been receiving favorable news coverage?
Media coverage about PETQ stock has trended neutral recently, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. PetIQ earned a news sentiment score of 0.1 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 4.0 out of 10, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near term.
Who are some of PetIQ's key competitors?
Who are PetIQ's key executives?
PetIQ's management team includes the folowing people:
- Mr. McCord Christensen, Chairman & CEO (Age 47)
- Mr. John Newland, CFO & Corp. Sec. (Age 55)
- Ms. Susan Sholtis, Pres (Age 53)
When did PetIQ IPO?
(PETQ) raised $86 million in an initial public offering on Friday, July 21st 2017. The company issued 5,700,000 shares at $14.00-$16.00 per share. Jefferies and William Blair acted as the underwriters for the IPO and Oppenheimer, Raymond James and SunTrust Robinson Humphrey were co-managers.
Who are PetIQ's major shareholders?
PetIQ's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Peregrine Capital Management LLC (2.19%), Steward Partners Investment Advisory LLC (0.10%), North Star Investment Management Corp. (0.09%) and Campbell Newman Asset Management Inc. (0.06%). Company insiders that own PetIQ stock include Ecp Helios Partners Iv, LP, James Nathan Clarke, John Newland, Mccord Christensen, Ronald Kennedy and Will Santana. View Institutional Ownership Trends for PetIQ.
Which institutional investors are buying PetIQ stock?
PETQ stock was bought by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, North Star Investment Management Corp., Steward Partners Investment Advisory LLC and Campbell Newman Asset Management Inc.. View Insider Buying and Selling for PetIQ.
How do I buy shares of PetIQ?
Shares of PETQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is PetIQ's stock price today?
One share of PETQ stock can currently be purchased for approximately $27.74.
How big of a company is PetIQ?
PetIQ has a market capitalization of $781.30 million and generates $266.69 million in revenue each year. The company earns $-3,490,000.00 in net income (profit) each year or $0.39 on an earnings per share basis. PetIQ employs 225 workers across the globe.
What is PetIQ's official website?
How can I contact PetIQ?
PetIQ's mailing address is 923 S. Bridgeway Pl., EAGLE ID, 83616. The company can be reached via phone at 208-939-8900 or via email at [email protected]
MarketBeat Community Rating for PetIQ (NASDAQ PETQ)
MarketBeat's community ratings are surveys of what our community members think about PetIQ and other stocks. Vote "Outperform" if you believe PETQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PETQ will underperform the S&P 500 over the long term. You may vote once every thirty days.
